RxDoctor Payments Data

Sarah Belden, DO

Dermatology · Middletown, RINPI 1356753974

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.9% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 17.5% — the pattern of someone who eats at a lot of different presentations.

$3,038in general payments, 2019–2025

Across 142 payments — averaging $21.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$533
  • Sanofi$495
  • LEO Pharma Inc.$375
  • Novartis$293
  • Johnson & Johnson$279
  • Lilly USA, LLC$225
  • plus $838 from 13 others

What the payments were for

  • Food & beverage$2,94397%
  • Education$953%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,038 in reported general payments places this provider in the 60th percentile of 61 dermatology providers in Rhode Island.

See all dermatology providers in Rhode Island

Medicare billing

Part B allowed, 2024
$163,117
Medicare patients
612
Services billed
2,392

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole435$8,440
Betamethasone Dipropionate162$6,572
Triamcinolone Acetonide252$4,132
Fluocinonide107$3,238
Ammonium Lactate107$2,895
Clindamycin Phosphate70$2,727
Metronidazole58$2,485
Azelaic Acid14$1,936
Doxycycline Monohydrate45$1,182
Clobetasol Propionate44$1,138
Fluorouracil17$1,006
Doxycycline Hyclate60$823
Permethrin19$808
Nystatin37$718
Minocycline Hcl23$561

Paid to pharmacies, not to this prescriber.

Other dermatology in Middletown

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →